Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,579.34
(
1.28%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
100.51
(
3.84%
)
Bitcoin
70,195.00
(
-0.99%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 57

Tuesday, 05/16/2006 3:33:43 PM

Tuesday, May 16, 2006 3:33:43 PM

Post# of 257273
GENR (if anyone still cares): on the ymb they are assuming that higher doses will improve Evizon’s tepid efficacy to date in U.S. trials, but I wouldn’t bet on it.

See slide #52 (at bottom) in #msg-1605364. The numbers speak for themselves and the slide’s caption says: “No Notable Difference in Study Eyes Response By Dose at End of Therapy and Follow-up.”

FWIW

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today